Natalie I. Vokes - Concepedia

Author

Natalie I. Vokes

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Jinsong Zhang, Lei Deng, Lingzhi Hong, N. I. Vokes, N. Vokes, N.I. Vokes, Natalie I Vokes, Natalie I. Vokes, Natalie Vokes, Natalie I. Vokes

347

Publications

8.5K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute Brigham and Women's Hospital Broad Institute Harvard University

About

Natalie I. Vokes is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	5.1K
2	Health Sciences	6	6	1.1K
3	Engineering	3	3	150
4	Arts	1	1	30
5	Public Health	1	1	30

Natalie I. Vokes

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis Jason W. Locasale, Alexandra Grassian, Tamar Melman, Nature Genetics BiochemistryPhosphoglycerate DehydrogenaseCatabolismMetabolismMedicine	2011	1.1K
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma David Liu, Bastian Schilling, Derek Liu, Nature Medicine	2019	1K
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities Carl M. Gay, C. Allison Stewart, Elizabeth M. Park, Cancer Cell ImmunogeneticsSystems BiologyDistinct Therapeutic VulnerabilitiesAutoimmune DiseaseTranscription Factor Programs	2021	864
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors Diana Miao, Claire A. Margolis, Natalie I. Vokes, Nature Genetics Cancer ImmunosurveillanceMedicineImmunologyCancer GenomicsGenomic Correlates	2018	683
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma Kevin Bi, Meng Xiao He, Ziad Bakouny, Cancer Cell ImmunologyImmune Cell TherapyImmunotherapyImmune Checkpoint BlockadeTumor Biology	2021	583
Tracing Compartmentalized NADPH Metabolism in the Cytosol and Mitochondria of Mammalian Cells Caroline A. Lewis, Seth J. Parker, Brian P. Fiske, Molecular Cell Energy MetabolismBiochemistryMitochondrial FunctionMammalian CellsMedicine	2014	574
Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells Sarah‐Maria Fendt, Eric L. Bell, Mark A. Keibler, Nature Communications Energy MetabolismMetabolic PathwaysBiochemistryPhysiologyCatabolism	2013	357
Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels Biagio Ricciuti, Xinan Wang, Joao V. Alessi, JAMA Oncology	2022	356
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status Biagio Ricciuti, Kathryn C. Arbour, Amir Vajdi, Journal of Thoracic Oncology Tumor BiologyProgrammed Death-MedicineCell DeathBronchial Neoplasm	2021	346
Transcriptional mediators of treatment resistance in lethal prostate cancer Meng Xiao He, Michael S. Cuoco, Jett Crowdis, Nature Medicine	2021	186

Page 1